THIEL-BACKED DRUG-ENHANCED SPORTS EVENT GOES PUBLIC

INDUSTRY DESK■ 1 MIN READ

SAT, MAY 9, 2026

■ AI-SUMMARIZED FROM 1 SOURCE ▸ TIMELINE

Enhanced, a company organizing an Olympics-style competition that permits performance-enhancing drugs, completed a SPAC merger valuing it at $1.2 billion. The Las Vegas event launches later this month with backing from Peter Thiel and former Coinbase CTO Balaji Srinivasan.

Enhanced went public through a merger with a blank-check company, securing $1.2 billion in valuation. The venture represents a departure from traditional sports governance, explicitly allowing athletes to use performance-enhancing substances. Co-founder and CEO Maximilian Martin announced the listing on the New York Stock Exchange floor. The company's model directly challenges conventional Olympic and competitive sports standards that prohibit such substances. Thiel's investment signals continued interest in contrarian ventures. Srinivasan's involvement connects the initiative to the broader crypto and tech investment sphere. The first event occurs in Las Vegas this month, testing whether audiences and athletes will embrace the alternative competition format. The move raises questions about regulatory oversight, athlete safety, and the future of performance-enhancement policies in organized sports.

■ SOURCES

► Bloomberg Tech

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE STARTUPS DESK

P696TRIOMICS RAISES $22M FOR AI ONCOLOGY PLATFORM

Triomics, an AI platform automating data-heavy tasks for oncologists, secured $22M in Series B funding. The raise follows a $15M Series A in 2024.

MAY 29— AI Desk

P697XCENA RAISES $135M FOR AI MEMORY CHIP TECH

Xcena secured $135 million in Series B funding at a $570 million valuation for its MX1 chip, which handles data orchestration and KV cache management directly within memory modules.

MAY 29— AI Desk

P677GRAY SWAN RAISES $40M TO EXPAND AI SECURITY

Pittsburgh-based Gray Swan, which stress-tests AI models for frontier labs, secured $40M in Series A funding at a $200M valuation. The round was co-led by Wing VC and Madrona.

MAY 29— AI Desk

P672H1 LANDS $40M FROM CVS HEALTH

H1, a healthcare SaaS startup, secured $40 million in funding from CVS Health. The investment signals continued investor confidence in specialized software platforms despite AI disruption concerns.

MAY 29— Industry Desk

◄ BACK TO NEWS

THIEL-BACKED DRUG-ENHANCED SPORTS EVENT GOES PUBLIC

■ MORE FROM THE STARTUPS DESK

■ SUBSCRIBE TO THE DAILY BRIEF